Related Experiment Video
Updated: May 14, 2026
09:45
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
CircPRKCA Promotes NSCLC Progression via miR-200b-3p/FRMD6/SNAI2 Axis
He Zhong1, Ning Wang1, Hui Zhang1
1Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
International Journal of Molecular Sciences
|May 13, 2026
Summary
Circular RNA PRKCA (circPRKCA) promotes non-small cell lung cancer (NSCLC) progression by sponging miR-200b-3p. This interaction prevents miR-200b-3p from degrading FRMD6 and SNAI2 mRNAs, thereby accelerating tumor growth.
Area of Science:
- Molecular Biology
- Oncology
- RNA Biology
Background:
- Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer progression.
- The specific functions of circPRKCA in non-small cell lung cancer (NSCLC) remain largely unknown.
- circPRKCA is notably overexpressed in NSCLC tissues and cells.
Purpose of the Study:
- To elucidate the mechanism by which circPRKCA influences NSCLC progression.
- To investigate the interaction between circPRKCA, miR-200b-3p, and target genes FRMD6 and SNAI2.
- To determine the role of circPRKCA as a potential therapeutic target in NSCLC.
Main Methods:
- Expression analysis of circPRKCA in NSCLC tissues and cells.
- Functional studies involving knockdown and overexpression of circPRKCA.
- RNA sequencing to identify mRNA correlations.
- Molecular sponge assays to demonstrate circPRKCA-miRNA interaction.
- Analysis of miRNA-mRNA binding and degradation pathways.
Main Results:
- circPRKCA is highly expressed in NSCLC and its knockdown inhibits malignant behaviors.
- circPRKCA acts as a molecular sponge for miR-200b-3p.
- miR-200b-3p targets the 3'UTRs of FRMD6 and SNAI2 mRNAs, promoting their degradation.
- Overexpression of circPRKCA counteracts miR-200b-3p-induced tumor suppression by inhibiting mRNA degradation.
Conclusions:
- circPRKCA accelerates NSCLC progression by acting as a sponge for miR-200b-3p.
- This sponging effect suppresses miR-200b-3p-mediated degradation of FRMD6 and SNAI2 mRNAs.
- circPRKCA represents a potential oncogenic driver and therapeutic target in NSCLC.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...